Kiyatec
PrivateLast Round
Strategic
Nov 13, 2025
Total Funding Raised
$31.73M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kiyatec operates in Healthcare & Life Sciences and is based in Greenville, South Carolina. Its latest recorded funding round was a Strategic round in November 2025.
Kiyatec is a functional precision oncology company that provides clinical testing and preclinical drug development services using proprietary 3D cell culture technology to predict patient-specific responses to cancer therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kiyatec Comparables
Compare Kiyatec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spanios | 84% | |
| Certis Oncology Solutions | 82% | |
| Invitrocue | 81% |
For institutional investors. Book with your work email.
Kiyatec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 13, 2025 | ||||
| Strategic | May 18, 2023 | ||||
| Series C | Dec 12, 2022 | ||||
| Corporate Funding | Dec 14, 2021 | ||||
| VC Round | Apr 30, 2021 | ||||
VC Round | Jan 8, 2020 |
For institutional investors. Book with your work email.
Kiyatec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Biomedical Imaging and Bioengineering | Grant |
| National Cancer Institute | Grant |
| The Sontag Foundation | Strategic |
| Seae Ventures | Series C, VC Round |
| Esperante | VC Round |
| SC Launch | Series A, VC Round |
| VentureSouth | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 87% MoM.
- Nov 13, 2025
Completed a strategic funding round.
For institutional investors. Book with your work email.
Kiyatec Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kiyatec's valuation, stock price, and market status.
Is Kiyatec a public or private company?
Kiyatec is a private company.
What is the current stock price of Kiyatec?
Kiyatec is a private company, so its shares have no public market price. Caplight tracks Kiyatec's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kiyatec worth (valuation)?
Valuation information for Kiyatec is not publicly available.
Can I buy Kiyatec stock?
Kiyatec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kiyatec's last funding round?
Kiyatec's most recent funding round was Strategic on November 13, 2025.
Who are the main investors in Kiyatec?
Key investors in Kiyatec include National Institute of Biomedical Imaging and Bioengineering, National Cancer Institute, Seae Ventures, SC Launch, VentureSouth.
Will Kiyatec IPO soon?
No public IPO plans have been announced for Kiyatec.
How can I track Kiyatec secondary market activity?
Caplight tracks bids, offers, and trades in Kiyatec's shares on secondary markets.